| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1047181286 |
| P356 | DOI | 10.1038/ONC.2011.222 |
| P932 | PMC publication ID | 3179812 |
| P698 | PubMed publication ID | 21685938 |
| P5875 | ResearchGate publication ID | 51231383 |
| P2093 | author name string | G Wong | |
| K Krueger | |||
| C Earle | |||
| C C Spevak | |||
| L Y W Bourguignon | |||
| P2860 | cites work | Regulation of stem cell pluripotency and differentiation involves a mutual regulatory circuit of the NANOG, OCT4, and SOX2 pluripotency transcription factors with polycomb repressive complexes and stem cell microRNAs. | Q37500527 |
| Role of Hyaluronan-Mediated CD44 Signaling in Head and Neck Squamous Cell Carcinoma Progression and Chemoresistance | Q37847694 | ||
| Establishment and characterization of a cisplatin-resistant oral squamous cell carcinoma cell line, H-1R. | Q38320162 | ||
| Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma | Q39966384 | ||
| Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer | Q40134000 | ||
| Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma | Q40361266 | ||
| Hyaluronan and tumor growth | Q42794422 | ||
| IAPs: from caspase inhibitors to modulators of NF-kappaB, inflammation and cancer | Q24292870 | ||
| Hyaluronan-mediated CD44 interaction with p300 and SIRT1 regulates beta-catenin signaling and NFkappaB-specific transcription activity leading to MDR1 and Bcl-xL gene expression and chemoresistance in breast tumor cells | Q24319922 | ||
| Principles of interleukin (IL)-6-type cytokine signalling and its regulation | Q24530173 | ||
| A microRNA expression signature of human solid tumors defines cancer gene targets | Q24541455 | ||
| Hyaluronan-CD44 Interaction Promotes c-Src-mediated Twist Signaling, MicroRNA-10b Expression, and RhoA/RhoC Up-regulation, Leading to Rho-kinase-associated Cytoskeleton Activation and Breast Tumor Cell Invasion | Q24608189 | ||
| CD44 variant isoforms in head and neck squamous cell carcinoma progression | Q24642719 | ||
| Global cancer statistics, 2002 | Q27860562 | ||
| Cancer statistics, 2008 | Q27860585 | ||
| The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells | Q28176663 | ||
| Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation | Q28288257 | ||
| STATs and Gene Regulation | Q29547796 | ||
| MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer | Q29616316 | ||
| Reduction of hyaluronan-CD44-mediated growth, migration, and cisplatin resistance in head and neck cancer due to inhibition of Rho kinase and PI-3 kinase signaling | Q33867608 | ||
| STAT signaling in head and neck cancer | Q33941351 | ||
| Signaling Properties of Hyaluronan Receptors | Q34444928 | ||
| Hyaluronan-Cell Interactions in Cancer and Vascular Disease | Q34444933 | ||
| MicroRNA alterations in head and neck squamous cell carcinoma. | Q35253630 | ||
| Hyaluronan-CD44 interaction activates stem cell marker Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells | Q36719279 | ||
| Regulation of metastases by signal transducer and activator of transcription 3 signaling pathway: clinical implications | Q36749049 | ||
| The inhibitors of apoptosis (IAPs) as cancer targets | Q36851057 | ||
| Hyaluronan-mediated CD44 activation of RhoGTPase signaling and cytoskeleton function promotes tumor progression | Q37152303 | ||
| SM-164: a novel, bivalent Smac mimetic that induces apoptosis and tumor regression by concurrent removal of the blockade of cIAP-1/2 and XIAP. | Q37445045 | ||
| Hyaluronan-CD44 interaction with protein kinase C(epsilon) promotes oncogenic signaling by the stem cell marker Nanog and the Production of microRNA-21, leading to down-regulation of the tumor suppressor protein PDCD4, anti-apoptosis, and chemothera | Q37446718 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | microRNA | Q310899 |
| head and neck squamous cell carcinoma | Q18348812 | ||
| P304 | page(s) | 149-160 | |
| P577 | publication date | 2011-06-20 | |
| P1433 | published in | Oncogene | Q1568657 |
| P1476 | title | Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cells | |
| P478 | volume | 31 |
| Q38741990 | 4-methylumbelliferone and imatinib combination enhances senescence induction in chronic myeloid leukemia cell lines |
| Q64244208 | A Novel Combination Cancer Therapy with Iron Chelator Targeting Cancer Stem Cells via Suppressing Stemness |
| Q41319418 | A Novel Role For Nanog As An Early Cancer Risk Marker In Patients With Laryngeal Precancerous Lesions |
| Q48026444 | A muscle-specific protein 'myoferlin' modulates IL-6/STAT3 signaling by chaperoning activated STAT3 to nucleus |
| Q35133375 | A novel curcumin analog (H-4073) enhances the therapeutic efficacy of cisplatin treatment in head and neck cancer |
| Q34623325 | AURKA regulates JAK2-STAT3 activity in human gastric and esophageal cancers |
| Q38779446 | Acquired cholesteatoma epithelial hyperproliferation: Roles of cell proliferation signal pathways |
| Q41661288 | Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells. |
| Q37695430 | Antibody against CD44s inhibits pancreatic tumor initiation and postradiation recurrence in mice. |
| Q42133030 | Bazedoxifene enhances the anti-tumor effects of cisplatin and radiation treatment by blocking IL-6 signaling in head and neck cancer |
| Q37619254 | Benzyl isothiocyanate inhibits HNSCC cell migration and invasion, and sensitizes HNSCC cells to cisplatin. |
| Q37470093 | Breast cancer adaptive resistance: HER2 and cancer stem cell repopulation in a heterogeneous tumor society |
| Q28084610 | CD44, Hyaluronan, the Hematopoietic Stem Cell, and Leukemia-Initiating Cells |
| Q58697956 | CD44/CD44v6 a Reliable Companion in Cancer-Initiating Cell Maintenance and Tumor Progression |
| Q41691889 | Cancer stem cell phenotypes and miRNA: therapeutic targets in head and neck squamous cell carcinoma |
| Q38972497 | Cell culture of human gingival fibroblasts, oral cancer cells and mesothelioma cells with serum-free media, STK1 and STK2 |
| Q37143946 | Circulating miR-21 as an independent predictive biomarker for chemoresistance in esophageal squamous cell carcinoma |
| Q39029327 | Cisplatin induces resistance by triggering differentiation of testicular embryonal carcinoma cells |
| Q38944423 | Co-targeting of multiple microRNAs on factor-Inhibiting hypoxia-Inducible factor gene for the pathogenesis of head and neck carcinomas |
| Q28083115 | Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target |
| Q28088370 | Concise Review: NANOG in Cancer Stem Cells and Tumor Development: An Update and Outstanding Questions |
| Q33898664 | Concurrent CD44s and STAT3 expression in human clear cell renal cellular carcinoma and its impact on survival |
| Q38724559 | Connective tissue growth factor promotes temozolomide resistance in glioblastoma through TGF-β1-dependent activation of Smad/ERK signaling |
| Q91924882 | Control Mechanisms of the Tumor Suppressor PDCD4: Expression and Functions |
| Q34431099 | Critical role for lysine 685 in gene expression mediated by transcription factor unphosphorylated STAT3. |
| Q92917120 | Cross-Roads to Drug Resistance and Metastasis in Breast Cancer: miRNAs Regulatory Function and Biomarker Capability |
| Q89432083 | Differential expression of hsa-miR-221, hsa-miR-21, hsa-miR-135b, and hsa-miR-29c suggests a field effect in oral cancer |
| Q60920503 | Differing Roles of Hyaluronan Molecular Weight on Cancer Cell Behavior and Chemotherapy Resistance |
| Q38023263 | Driving Apoptosis-relevant Proteins Toward Neural Differentiation |
| Q42140117 | Effect of radiotherapy on expression of hyaluronan and EGFR and presence of mast cells in squamous cell carcinoma of the head and neck |
| Q41040518 | Effect of shRNA-Mediated Gene Silencing of Bmi-1 Expression on Chemosensitivity of CD44+ Nasopharyngeal Carcinoma Cancer Stem-Like Cells |
| Q37407342 | Effects of microRNA-21 on the biological functions of T-cell acute lymphoblastic lymphoma/leukemia |
| Q53111016 | Embryonic stem cells markers Oct4 and Nanog correlate with perineural invasion in human salivary gland mucoepidermoid carcinoma |
| Q38971467 | Emerging role of microRNA-21 in cancer |
| Q33786554 | Emerging role of nanog in tumorigenesis and cancer stem cells |
| Q98735914 | Enhanced Expression of ABCB1 and Nrf2 in CD133-Positive Cancer Stem Cells Associates with Doxorubicin Resistance |
| Q35748408 | Exosomes/microvesicles from induced pluripotent stem cells deliver cardioprotective miRNAs and prevent cardiomyocyte apoptosis in the ischemic myocardium. |
| Q90748923 | Expression of Cancer Stem Cell Biomarkers in Human Head and Neck Carcinomas: a Systematic Review |
| Q98178522 | Expression of NANOG and Its Regulation in Oral Squamous Cell Carcinoma |
| Q58695542 | GPRC5A: An Emerging Biomarker in Human Cancer |
| Q47140728 | Genetic and pharmacological inhibition of microRNA-92a maintains podocyte cell cycle quiescence and limits crescentic glomerulonephritis |
| Q36544516 | HDAC inhibitor AR-42 decreases CD44 expression and sensitizes myeloma cells to lenalidomide |
| Q36670686 | HER2-associated radioresistance of breast cancer stem cells isolated from HER2-negative breast cancer cells |
| Q60302891 | HJC0152, a novel STAT3 inhibitor with promising anti-tumor effect in gastric cancer |
| Q36310047 | Human liver stem cell-derived microvesicles inhibit hepatoma growth in SCID mice by delivering antitumor microRNAs. |
| Q37683868 | Hyaluronan-CD44 interaction promotes c-Jun signaling and miRNA21 expression leading to Bcl-2 expression and chemoresistance in breast cancer cells |
| Q39599761 | Hyaluronan-CD44 interaction promotes microRNA signaling and RhoGTPase activation leading to tumor progression |
| Q38235802 | Hyaluronan-CD44 interaction promotes oncogenic signaling, microRNA functions, chemoresistance, and radiation resistance in cancer stem cells leading to tumor progression. |
| Q36294783 | Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma |
| Q38955458 | Hyaluronic acid promotes the expression of progesterone receptor membrane component 1 via epigenetic silencing of miR-139-5p in human and rat granulosa cells |
| Q47681462 | Hypoxia-Inducible Factors and Cancer |
| Q38206794 | Illustrating the interplay between the extracellular matrix and microRNAs. |
| Q38868664 | Immunohistochemical analysis of EGFR and hyaluronan in tongue cancer and the development of regional recurrence in patients initially diagnosed N0. |
| Q38040787 | Implication of tumor microenvironment in chemoresistance: tumor-associated stromal cells protect tumor cells from cell death |
| Q61796805 | Inhibition of 5-lipoxygenase downregulates stemness and kills prostate cancer stem cells by triggering apoptosis via activation of c-Jun N-terminal kinase |
| Q26863279 | Integrating non-coding RNAs in JAK-STAT regulatory networks |
| Q92003604 | KIF20A promotes cellular malignant behavior and enhances resistance to chemotherapy in colorectal cancer through regulation of the JAK/STAT3 signaling pathway |
| Q50460243 | Linc-RNA-RoR acts as a "sponge" against mediation of the differentiation of endometrial cancer stem cells by microRNA-145. |
| Q26748929 | Matrix Hyaluronan Promotes Specific MicroRNA Upregulation Leading to Drug Resistance and Tumor Progression |
| Q91786123 | Matrix Hyaluronan-CD44 Interaction Activates MicroRNA and LncRNA Signaling Associated With Chemoresistance, Invasion, and Tumor Progression |
| Q36866396 | MiR-134 regulates the proliferation and invasion of glioblastoma cells by reducing Nanog expression |
| Q38122420 | MicroRNA-21: a therapeutic target for reversing drug resistance in cancer |
| Q26778591 | MicroRNAs as Important Players and Biomarkers in Oral Carcinogenesis |
| Q89578384 | MicroRNAs as Theranostics Targets in Oral Carcinoma Stem Cells |
| Q38086010 | MicroRNAs regulate both epithelial-to-mesenchymal transition and cancer stem cells |
| Q42080548 | NANOG expression correlates with differentiation, metastasis and resistance to preoperative adjuvant therapy in oral squamous cell carcinoma |
| Q38800311 | NANOG regulates epithelial-mesenchymal transition and chemoresistance through activation of the STAT3 pathway in epithelial ovarian cancer |
| Q38256341 | NANOG: a promising target for digestive malignant tumors |
| Q64057123 | Nanog Signaling Mediates Radioresistance in ALDH-Positive Breast Cancer Cells |
| Q28540510 | Nanog1 in NTERA-2 and recombinant NanogP8 from somatic cancer cells adopt multiple protein conformations and migrate at multiple M.W species |
| Q54311494 | Nanog: a potential biomarker for liver metastasis of colorectal cancer |
| Q33734466 | Natural and synthetic progestins enrich cancer stem cell-like cells in hormone-responsive human breast cancer cell populations in vitro |
| Q36878785 | Over expression of hyaluronan promotes progression of HCC via CD44-mediated pyruvate kinase M2 nuclear translocation |
| Q36756314 | Overexpression of microRNA-21 is associated with elevated pro-inflammatory cytokines in dominant-negative TGF-β receptor type II mouse |
| Q26741215 | Pancreatic cancer stem cell markers and exosomes - the incentive push |
| Q33920265 | Pharmaco-miR: linking microRNAs and drug effects |
| Q32884401 | Phosphorylation of Nanog is essential to regulate Bmi1 and promote tumorigenesis |
| Q90607610 | Preoperative assessment of CD44-mediated depth of invasion as predictor of occult metastases in early oral squamous cell carcinoma |
| Q26769034 | Prognostic Value and Clinicopathological Significance of p-stat3 Among Gastric Carcinoma Patients: A Systematic Review and Meta-Analysis |
| Q59072618 | Protein Kinase C (PKC) Isozymes and Cancer |
| Q52715010 | RNA-Seq profiling of circular RNAs in human laryngeal squamous cell carcinomas. |
| Q38075424 | Redox regulation in stem-like cancer cells by CD44 variant isoforms. |
| Q37936584 | Regulation of microRNA expression and function by nuclear receptor signaling |
| Q38770102 | Role of Pericellular Matrix in the Regulation of Cancer Stemness |
| Q90149278 | Role of miRNA-Regulated Cancer Stem Cells in the Pathogenesis of Human Malignancies |
| Q36559375 | STAT3 is Overactivated in Gastric Cancer Stem-Like Cells |
| Q28118347 | STAT3 upregulates miR-92a to inhibit RECK expression and to promote invasiveness of lung cancer cells |
| Q64261046 | STOML2 as a novel prognostic biomarker modulates cell proliferation, motility and chemo-sensitivity via IL6-Stat3 pathway in head and neck squamous cell carcinoma |
| Q36089284 | Selective Activation of Cancer Stem Cells by Size-Specific Hyaluronan in Head and Neck Cancer |
| Q33635277 | Serglycin in tumor microenvironment promotes non-small cell lung cancer aggressiveness in a CD44-dependent manner |
| Q34902060 | Signaling Networks of Activated Oncogenic and Altered Tumor Suppressor Genes in Head and Neck Cancer |
| Q37432727 | Smoking and microRNA dysregulation: a cancerous combination |
| Q48199478 | Snail-mediated cancer stem cell-like phenotype in human CNE2 nasopharyngeal carcinoma cell |
| Q38849205 | Stat3 regulates ErbB-2 expression and co-opts ErbB-2 nuclear function to induce miR-21 expression, PDCD4 downregulation and breast cancer metastasis. |
| Q38658623 | Stem cell transcription factor NANOG in cancers--is eternal youth a curse? |
| Q40521844 | Suberoylanilide hydroxamic acid (SAHA) reverses chemoresistance in head and neck cancer cells by targeting cancer stem cells via the downregulation of nanog |
| Q37596880 | Suppressing role of miR-520a-3p in breast cancer through CCND1 and CD44. |
| Q38718723 | Suppression of the Growth and Invasion of Human Head and Neck Squamous Cell Carcinomas via Regulating STAT3 Signaling and the miR-21/β-catenin Axis with HJC0152. |
| Q36654413 | TLR2 enhances ovarian cancer stem cell self-renewal and promotes tumor repair and recurrence |
| Q45925124 | TSSC3 represses self-renewal of osteosarcoma stem cells and Nanog expression by inhibiting the Src/Akt pathway. |
| Q38485889 | Targeting JAK kinase in solid tumors: emerging opportunities and challenges |
| Q89355507 | Targeting Notch1 and IKKα Enhanced NF-κB Activation in CD133+ Skin Cancer Stem Cells |
| Q38937280 | Targeting cancer stem cell-specific markers and/or associated signaling pathways for overcoming cancer drug resistance |
| Q37170030 | Targeting cancer stem cells: emerging role of Nanog transcription factor |
| Q98466261 | Targeting the Extra-Cellular Matrix-Tumor Cell Crosstalk for Anti-Cancer Therapy: Emerging Alternatives to Integrin Inhibitors |
| Q28071619 | The Progress and Prospects of Putative Biomarkers for Liver Cancer Stem Cells in Hepatocellular Carcinoma |
| Q38932015 | The ability of hyaluronan fragments to reverse the resistance of C6 rat glioma cell line to temozolomide and carmustine |
| Q39029645 | The inhibition of miR-21 promotes apoptosis and chemosensitivity in ovarian cancer |
| Q35623354 | The pluripotency factor NANOG promotes the formation of squamous cell carcinomas |
| Q28085385 | The role of NANOG transcriptional factor in the development of malignant phenotype of cancer cells |
| Q40990151 | The role of microRNAs in head and neck squamous cell carcinoma : Biomarkers for prognosis, therapy selection, and novel therapeutics |
| Q34733033 | Tumor suppressive microRNA-193b promotes breast cancer progression via targeting DNAJC13 and RAB22A. |
| Q36898208 | Up-regulation of Histone Methyltransferase, DOT1L, by Matrix Hyaluronan Promotes MicroRNA-10 Expression Leading to Tumor Cell Invasion and Chemoresistance in Cancer Stem Cells from Head and Neck Squamous Cell Carcinoma |
| Q37641610 | Up-regulation of miR-187 modulates the advances of oral carcinoma by targeting BARX2 tumor suppressor |
| Q34719683 | WP1066 sensitizes oral squamous cell carcinoma cells to cisplatin by targeting STAT3/miR-21 axis |
| Q26745972 | Yin Yang 1 is associated with cancer stem cell transcription factors (SOX2, OCT4, BMI1) and clinical implication |
| Q38943076 | ZEB1 as an indicator of tumor recurrence for areca quid chewing-associated oral squamous cell carcinomas |
| Q36154926 | miR-21 Inhibition Reduces Liver Fibrosis and Prevents Tumor Development by Inducing Apoptosis of CD24+ Progenitor Cells |
| Q39028904 | miR-31 is upregulated in oral premalignant epithelium and contributes to the immortalization of normal oral keratinocytes |
| Q37636790 | miR-31 targets ARID1A and enhances the oncogenicity and stemness of head and neck squamous cell carcinoma |
| Q38088011 | miRNAs and long noncoding RNAs as biomarkers in human diseases |
Search more.